<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Subst Use Addict Treat</journal-id><journal-id journal-id-type="iso-abbrev">J Subst Use Addict Treat</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Journal of substance use and addiction treatment</journal-title></journal-title-group><issn pub-type="ppub">2949-8767</issn><issn pub-type="epub">2949-8759</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11926888</article-id><article-id pub-id-type="pmcid-ver">PMC11926888.1</article-id><article-id pub-id-type="pmcaid">11926888</article-id><article-id pub-id-type="pmcaiid">11926888</article-id><article-id pub-id-type="manuscript-id">NIHMS2032786</article-id><article-id pub-id-type="pmid">39437904</article-id><article-id pub-id-type="doi">10.1016/j.josat.2024.209544</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS2032786</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA2032786</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Relationship of Hub and Treatment Characteristics with Client
Outcomes in the Initial Washington State Hub and Spoke Cohort</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Reif</surname><given-names initials="S">Sharon</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Stewart</surname><given-names initials="MT">Maureen T.</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Daily</surname><given-names initials="SM">Shay M.</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Brolin</surname><given-names initials="MF">Mary F.</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lee</surname><given-names initials="MT">Margaret T.</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Panas</surname><given-names initials="L">Lee</given-names></name><degrees>MS</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ritter</surname><given-names initials="G">Grant</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shields</surname><given-names initials="MC">Morgan C.</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">a</xref><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mazel</surname><given-names initials="SB">Shayna B.</given-names></name><degrees>PhD, MPP</degrees><xref rid="A1" ref-type="aff">a</xref><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wicks</surname><given-names initials="JJ">Jennifer J.</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">a</xref></contrib></contrib-group><aff id="A1"><label>a</label>Institute for Behavioral Health, Heller School for Social
Policy and Management, Brandeis University, 415 South Street MS 35, Waltham, MA
02453 USA</aff><aff id="A2"><label>b</label>Brown School, Washington University, 1 Brookings Drive, St.
Louis, MO 63130 USA</aff><aff id="A3"><label>c</label>NYU Grossman School of Medicine, 180 Madison Avenue, New
York, NY 10016</aff><author-notes><corresp id="CR1"><bold>Corresponding Author:</bold> Sharon Reif, PhD; Professor,
Institute for Behavioral Health, Schneider Institutes for Health Policy and
Research, Heller School for Social Policy and Management, Brandeis University,
415 South Street MS 035, Waltham, MA 02453;
<email>reif@brandeis.edu</email></corresp><fn fn-type="COI-statement" id="FN2"><p id="P71"><bold>Declaration of interest:</bold> None.</p></fn></author-notes><pub-date pub-type="ppub"><month>1</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>20</day><month>10</month><year>2024</year></pub-date><volume>168</volume><issue-id pub-id-type="pmc-issue-id">484859</issue-id><fpage>209544</fpage><lpage>209544</lpage><pub-history><event event-type="nihms-submitted"><date><day>04</day><month>01</month><year>2025</year></date></event><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2026</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-03-22 10:25:40.850"><day>22</day><month>03</month><year>2025</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-2032786.pdf"/><abstract id="ABS1"><sec id="S1"><title>Introduction:</title><p id="P1">Washington State&#8217;s Hub and Spoke (HS) approach aims to improve
availability of opioid use disorder (OUD) treatment. Washington initially
funded six hubs with expertise in medications for opioid use disorder (MOUD)
that built care networks with referral and treatment partners (spokes). We
assessed outcomes for the initial HS cohort, considering the role of HS and
treatment characteristics.</p></sec><sec id="S2"><title>Methods:</title><p id="P2">We conducted a cohort-based observational study using
2017&#8211;2019 Medicaid claims data for 2,841 HS participants aged
18&#8211;64, excluding those with past-month MOUD, in an intent-to-treat
analysis. We describe treatment characteristics (MOUD type, treatment
setting, and hub type at the initial HS visit, number of outpatient services
in their first HS month), and six-month outcomes (MOUD continuity, emergency
department (ED) utilization, hospitalization, and intensive SUD treatment).
We used multivariable regressions to assess associations with six-month
outcomes, adjusting for client characteristics.</p></sec><sec id="S3"><title>Results:</title><p id="P3">Two-thirds (68%) of participants received buprenorphine, 22%
methadone, 5% naltrexone, and 5% outpatient without MOUD for their initial
visit. Within six months, 45% had an ED visit, 14% any hospitalization, and
18% entered intensive SUD treatment. Only 24% remained on MOUD for six
months. Compared to buprenorphine, the methadone sample had higher odds of
MOUD continuity (aOR=2.81, 95%CI 2.21&#8211;3.55), and the naltrexone
sample had lower odds (aOR=0.36, 95%CI 0.19&#8211;0.66). FQHC/public health
treatment settings had higher odds of MOUD continuity (aOR=1.70, 95%CI
1.17&#8211;2.47) but hub type was not significant. MOUD continuity
increased with 2+ outpatient services for the buprenorphine sample (aOR
range 2.55&#8211;4.73). Odds of intensive SUD treatment were lower for the
methadone sample, compared to buprenorphine (aOR=0.16, 95%CI
0.11&#8211;0.23), all settings compared to SUD settings (aOR range
0.32&#8211;0.58), and SUD+MH and medical/hospital hubs compared to SUD only
hubs (aOR range 0.28&#8211;0.41).</p></sec><sec id="S4"><title>Conclusions:</title><p id="P4">Most participants did not attain six-month MOUD continuity, despite
the HS approach, with variations by MOUD type and treatment setting. The
number of outpatient services in the first month for buprenorphine clients
was associated with greater odds of MOUD continuity and reduced odds of
intensive SUD treatment. More work is needed to improve MOUD continuity for
people with OUD within the HS model.</p></sec></abstract><kwd-group><kwd>opioid use disorder</kwd><kwd>medication</kwd><kwd>MOUD</kwd><kwd>outpatient treatment</kwd><kwd>treatment setting</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-exception-type</meta-name><meta-value>EMBARGO</meta-value></custom-meta><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>4</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>no</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>